The role of lung dendritic cell subsets in immunity to respiratory viruses

Immunological Reviews

Volumn 255, Issue 1, 2013, Pages 57-67

  Neyt, Katrijn ^a,b   Lambrecht, Bart N ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Airways; Dendritic cell; Lung; Viral infection

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; LATE ACTIVATOR ANTIGEN PRESENTING CELL; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY VIRUS; REVIEW; STEADY STATE; VIRAL RESPIRATORY TRACT INFECTION;

AIRWAYS; DENDRITIC CELL; LUNG; VIRAL INFECTION;

ANIMALS; DENDRITIC CELLS; HUMANS; LUNG; MICE; VIRUS DISEASES; VIRUSES;

EID: 84881656583     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12100     Document Type: Review

References (119)

1. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009;10:1237-1244.
2. Guilliams M, et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol 2010;40:2089-2094.
3. GeurtsvanKessel CH, et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med 2008;205:1621-1634.
4. Desch AN, et al. Efferocytic CD103+ pulmonary dendritic cells selectively acquire and present apoptotic cell-associated antigen. J Exp Med 2011;208:1789-1797.
5. Sung SS, et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006;176:2161-2172.
6. Beaty SR, et al. Diverse and potent chemokine production by lung dendritic cells in homeostasis and in allergic lung inflammation. J Immunol 2007;178:1882-1895.
7. van Rijt LS, et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005;201:981-991.
8. Hammad H, et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009;15:410-416.
9. Kool M, et al. An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J Immunol 2009;183:1074-1082.
10. de Heer HJ, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004;200:89-98.
11. Wikstrom ME, Stumbles PA. Mouse respiratory tract dendritic cell subsets and the immunological fate of inhaled antigens. Immunol Cell Biol 2007;85:182-188.
12. von Garnier C, et al. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J Immunol 2005;175:1609-1618.
13. Willart MA, et al. The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen. J Exp Med 2009;206:2823-2835.
14. Sertl K, et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med 1986;163:436-451.
15. Meredith MM, et al. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 2012;209:1153-1165.
16. Satpathy AT, et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 2012;209:1135-1152.
17. Meredith MM, et al. Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 2012;209:1583-1593.
18. GeurtsvanKessel CH, et al. Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection. PLoS ONE 2009;4:e7187.
19. Jakubzick C, et al. Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen. J Immunol Methods 2008;337:121-131.
20. Grayson MH, et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med 2007;204:2759-2769.
21. Cheong C, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010;143:416-429.
22. Leon B, et al. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007;26:519-531.
23. Plantinga M, et al. Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013; 38: 322-335.
24. Hammad H, et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010;207:2097-2111.
25. Langlet C, et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J Immunol 2012;188:1751-1760.
26. Tamoutounour S, et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 2012;42:3150-3166.
27. Jakubzick C, et al. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med 2008;205:2839-2850.
28. Johnson TR, et al. Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS ONE 2011;6:e16458.
29. Guerrero-Plata A, et al. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Resp Cell Mol Biol 2006;34:320-329.
30. Arpaia N, Barton GM. Toll-like receptors: key players in antiviral immunity. Curr Opin Virol 2011;1:447-454.
31. Lopez CB, et al. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol 2004;173:6882-6889.
32. Ireton RC, Gale M Jr. RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses 2011;3:906-919.
33. Kim T, et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA 2010;107:15181-15186.
34. Zhang Z, et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011;34:866-878.
35. Zhang Z, et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011;12:959-965.
36. Zhang Z, et al. DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. J Immunol 2011;187:4501-4508.
37. Parvatiyar K, et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012;13:1155-1161.
38. Jacobs SR, Damania B. NLRs, inflammasomes, and viral infection. J Leuk Biol 2012;92:469-477.
39. van Drunen Littel-van den Hurk S, Watkiss ER. Pathogenesis of respiratory syncytial virus. Curr Opin Virol 2012;2:300-305.
40. van de Sandt CE, et al. Evasion of influenza a viruses from innate and adaptive immune responses. Viruses 2012;4:1438-1476.
41. Rosenberger CM, et al. miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 2012;189:5965-5975.
42. Walter MJ, et al. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 2001;193:339-351.
43. Greter M, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012;36:1031-1046.
44. Willart MA, et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012;209:1505-1517.
45. Pang IK, et al. IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8(+) T cell responses to influenza A virus. Nat Immunol 2013;14:246-253.
46. Yadava K, et al. TSLP promotes influenza-specific CD8+ T-cell responses by augmenting local inflammatory dendritic cell function. Mucosal Immunol 2013;6:83-92.
47. Rudd BD, et al. Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol 2007;20:531-540.
48. Rate A, et al. Airway epithelial cells regulate the functional phenotype of locally differentiating dendritic cells: implications for the pathogenesis of infectious and allergic airway disease. J Immunol 2009;182:72-83.
49. Kumagai Y, et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 2007;27:240-252.
50. Ge MQ, et al. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-gamma and perforin-dependent mechanisms. J Immunol 2012;189:2099-2109.
51. van Gisbergen KP, et al. Neutrophils mediate immune regulation of dendritic cells through glycosylation-dependent interactiona between Mac-1 and DC-SIGN. J Exp Med 2005;201:1281-1292.
52. Brinker KG, et al. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. American journal of physiology. Lung Cell Mol Pathol 2003;284:L232-241.
53. Brinker KG, et al. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol 2001;281:L1453-1463.
54. Hansen S, et al. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Resp Cell Mol Biol 2007;36:94-102.
55. Kandasamy M, et al. Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection. PLoS Pathog 2013;9:e1003115.
56. Lin KL, et al. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008;180:2562-2572.
57. Grayson MH, et al. Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol 2007;179:1438-1448.
58. del Rio M-L, et al. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J Immunol 2007;178:6861-6866.
59. Hintzen G, et al. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol 2006;177:7346-7354.
60. Heer AK, et al. CD4+ and CD8+ T cells exhibit differential requirements for CCR7-mediated antigen transport during influenza infection. J Immunol 2008;181:6984-6994.
61. Legge KL, Braciale TJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 2003;18:265-277.
62. Zhao J, et al. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest 2011;121:4921-4930.
63. Hammad H, et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003;171:3936-3940.
64. Le Nouen C, et al. Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS ONE 2010;5:e15017.
65. Le Nouen C, et al. Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus. PLoS Pathog 2011;7:e1002105.
66. Lambrecht BN, Hammad H. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Ann Rev Immunol 2012;30:243-270.
67. Kim TS, Braciale TJ. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 2009;4:e4204.
68. Belz GT, et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci USA 2004;101:8670-8675.
69. GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol 2008;1:442-450.
70. Helft J, et al. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest 2012;122:4037-4047.
71. Smyth LA, et al. Acquisition of MHC:peptide complexes by dendritic cells contributes to the generation of antiviral CD8+ T cell immunity in vivo. J Immunol 2012;189:2274-2282.
72. Li L, et al. Cross-dressed CD8alpha+/CD103+ dendritic cells prime CD8+ T cells following vaccination. Proc Natl Acad Sci USA 2012;109:12716-12721.
73. Legge KL, Braciale TJ. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 2005;23:649-659.
74. Moltedo B, et al. Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog 2011;7:e1002345.
75. Ho AW, et al. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol 2011;187:6011-6021.
76. Iborra S, et al. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest 2012;122:1628-1643.
77. Schreibelt G, et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-) presentation by human blood BDCA3+ myeloid dendritic cells. Blood 2012;119:2284-2292.
78. Zelenay S, et al. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 2012;122:1615-1627.
79. Poulin LF, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 2012;119:6052-6062.
80. Ballesteros-Tato A, et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat Immunol 2010;11:216-224.
81. Yoon H, et al. Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol 2007;179:391-399.
82. Lukens MV, et al. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol 2009;83:7235-7243.
83. Beauchamp NM, et al. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol 2010;84:10191-10199.
84. Beauchamp NM, et al. CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation. J Virol 2012;86:10640-10650.
85. Osterholzer JJ, et al. Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J Immunol 2009;183:8044-8053.
86. Seo SU, et al. Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 2011;7:e1001304.
87. Cao W, et al. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection. J Immunol 2012;189:2257-2265.
88. Gill MA, et al. Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis 2008;198:1667-1676.
89. Lin KL, et al. CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J Immunol 2011;186:508-515.
90. Aldridge JR Jr, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009;106:5306-5311.
91. Narni-Mancinelli E, et al. Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. J Exp Med 2007;204:2075-2087.
92. Narni-Mancinelli E, et al. Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo. PLoS Pathog 2011;7:e1002457.
93. Yoo JK, et al. Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity. J Exp Med 2010;207:1435-1451.
94. Yoo JK, et al. LAPCs promote follicular helper T cell differentiation of antigen-primed CD4+ T cells during respiratory virus infection. J Exp Med 2012;209:1853-1867.
95. Yoo JK, et al. Interferon-beta modulates type 1 immunity during influenza virus infection. Antiviral Res 2010;88:64-71.
96. Wang H, et al. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 2006;177:6263-6270.
97. Smit JJ, et al. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006;203:1153-1159.
98. Davidson S, et al. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol 2011;186:5938-5948.
99. Boogaard I, et al. Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells. Immunology 2007;122:65-72.
100. Jewell NA, et al. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol 2007;81:9790-9800.
101. Fonteneau JF, et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003;101:3520-3526.
102. Cella M, et al. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000;1:305-310.
103. Hoeffel G, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007;27:481-492.
104. Kool M, et al. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs. J Leukoc Biol 2011;90:1177-1190.
105. Wolf AI, et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J Immunol 2009;182:871-879.
106. Langlois RA, Legge KL. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J Immunol 2010;184:4440-4446.
107. Jego G, et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003;19:225-234.
108. Swiecki M, et al. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med 2011;208:2367-2374.
109. Swiecki M, et al. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010;33:955-966.
110. Lombardi V, et al. CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol 2010;5:432-443.
111. Smit JJ, et al. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS ONE 2008;3:e1720.
112. Rimmelzwaan GF, et al. Inhibition of influenza virus replication by nitric oxide. J Virol 1999;73:8880-8883.
113. Hufford MM, et al. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med 2011;208:167-180.
114. McGill J, et al. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 2010;207:521-534.
115. Humphreys IR, et al. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 2003;198:1237-1242.
116. Han J, et al. Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol 2012;130:1175-1186.
117. Neyt K, et al. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 2012;33:297-305.
118. GeurtsvanKessel CH, et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009;206:2339-2349.
119. Halle S, et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 2009;206:2593-2601.